Formulation Licenses
Registered finished dosage forms (FDF), transferable tech packages and in-development in-licensing pipelines · delivered per target-market approval pathway
Licensing pipeline
TLR9
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB432)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- United States
Licensing pipeline
DLL3 BsAb + Dual-payload
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB431)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
Insulin receptor
—
- Therapy
- Metabolic & Endocrinology
- Status
- Candidate licensing (UB430)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
Steroid + VD
—
- Therapy
- Immunology & Inflammation
- Status
- Candidate licensing (UB429)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
PDE4
—
- Therapy
- Immunology & Inflammation
- Status
- Candidate licensing (UB428)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
OX40L x TNFα； OX40L
—
- Therapy
- Immunology & Inflammation
- Status
- Candidate licensing (UB427)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
CD19
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB425)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
BCMA
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB424)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
Neuroprotective
—
- Therapy
- Cardiovascular
- Status
- Candidate licensing (UB422)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
Retina
—
- Therapy
- Ophthalmology
- Status
- Candidate licensing (UB418)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
UB413
—
- Therapy
- Ophthalmology
- Status
- Candidate licensing (UB413)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
UB412
—
- Therapy
- Ophthalmology
- Status
- Candidate licensing (UB412)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
Functional fragment of Thymosin β4
—
- Therapy
- Ophthalmology
- Status
- Candidate licensing (UB411)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
HER2
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB410)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
HER2
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB409)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
BCMA/CD3
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB408)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
WFS1
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB407)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
BTK/LYN
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB405)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
MENIN
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB404)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
USP1
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB401)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
PARP1
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB400)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
Pan RAS
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB399)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
EGFR/cMet
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB396)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
CDK2/4/6
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB395)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
GPC3
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB394)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
ITGB6
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB393)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
CLDN6
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB392)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
Her2/Her2
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB391)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
ROR1
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB390)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
ER
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB389)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
AR
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB388)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
BTK
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB387)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
AT2R
—
- Therapy
- Neurology
- Status
- Candidate licensing (UB386)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
STAT6
—
- Therapy
- Immunology & Inflammation
- Status
- Candidate licensing (UB381)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
ActRIIA/B
—
- Therapy
- Metabolic & Endocrinology
- Status
- Candidate licensing (UB377)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
GLP-1R
—
- Therapy
- Metabolic & Endocrinology
- Status
- Candidate licensing (UB376)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China, United States
Licensing pipeline
UB375
—
- Therapy
- Metabolic & Endocrinology
- Status
- Candidate licensing (UB375)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
UB374
—
- Therapy
- Metabolic & Endocrinology
- Status
- Candidate licensing (UB374)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
TL1A
—
- Therapy
- Immunology & Inflammation
- Status
- Candidate licensing (UB373)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
WRN
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB372)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
MAT2A
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB371)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
ATM
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB370)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
ER-PROTAC
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB369)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
BTK-PROTAC
—
- Therapy
- Immunology & Inflammation
- Status
- Candidate licensing (UB368)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
IL-17A/F
—
- Therapy
- Dermatology
- Status
- Candidate licensing (UB367)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
TRKA/B/C
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB366)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China, United States
Licensing pipeline
TRKA (Gel)
—
- Therapy
- Dermatology
- Status
- Candidate licensing (UB365)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
JAK1 (oral)
—
- Therapy
- Immunology & Inflammation
- Status
- Candidate licensing (UB364)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China